Data integrity of 35 randomised controlled trials in women' health.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 16 03 2020
revised: 27 03 2020
accepted: 02 04 2020
pubmed: 10 5 2020
medline: 6 3 2021
entrez: 9 5 2020
Statut: ppublish

Résumé

While updating a systematic review on the topic of ovulation of induction, we observed unusual similarities in a number of randomised controlled trials (RCTs) published by two authors from the same institute in the same disease spectrum in a short period of time. We therefore undertook a focused analysis of the data integrity of all RCTs published by the two authors. We made pairwise comparisons to find identical or similar values in baseline characteristics and outcome tables between trials. We also assessed whether baseline characteristics were compatible with chance, using Monte Carlo simulations and Kolmogorov-Smirnov test. For 35 trials published between September 2006 and January 2016, we found a large number of similarities in both the baseline characteristics and outcomes of 26. Analysis of the baseline characteristics of the trials indicated that their distribution was unlikely to be the result of proper randomisation. The procedures demonstrated in this paper may help to assess data integrity in future attempts to verify the authenticity of published RCTs.

Identifiants

pubmed: 32381348
pii: S0301-2115(20)30184-6
doi: 10.1016/j.ejogrb.2020.04.016
pii:
doi:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

72-83

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest LMA is a co-convener of the Cochrane Prospective Meta-analysis Methods Group and manager of the Australian New Zealand Clinical Trials Registry. MvW is co-oordinating editor of the Netherlands Satellite of the Cochrane Gynaecology and Fertiliy Group. BWM reports grants from NHMRC, personal fees from ObsEva, personal fees from Merck Merck KGaA, personal fees from Guerbet, personal fees from iGenomix, outside the submitted work. All other authors have no conflicts of interest.

Auteurs

Esmée M Bordewijk (EM)

Department of Obstetrics and Gynecology, Monash University, Clayton, Australia; Centre for Reproductive Medicine, Amsterdam UMC, Amsterdam, the Netherlands. Electronic address: e.m.bordewijk@amsterdamumc.nl.

Rui Wang (R)

Department of Obstetrics and Gynecology, Monash University, Clayton, Australia.

Lisa M Askie (LM)

NHMRC Clinical Trials Centre, University of Sydney, Australia.

Lyle C Gurrin (LC)

Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Parkville, Australia.

Jim G Thornton (JG)

Faculty of Medicine & Health Sciences, University of Nottingham, Nottingham, United Kingdom.

Madelon van Wely (M)

Centre for Reproductive Medicine, Amsterdam UMC, Amsterdam, the Netherlands.

Wentao Li (W)

Department of Obstetrics and Gynecology, Monash University, Clayton, Australia.

Ben W Mol (BW)

Department of Obstetrics and Gynecology, Monash University, Clayton, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH